Medtronic has announced that Michelle Quinn will become its new general counsel, joining from Becton, Dickinson and Co. (BD) where she currently holds the same position. Quinn, who brings a wealth of legal experience in the medical technology sector, has been with BD since 2019. Her appointment is particularly timely as Medtronic prepares for a significant organizational restructuring.
The outgoing general counsel, Ivan Fong, will be retiring on July 21. Fong has served in this role since 2022, after a distinguished legal career that has included positions across both the public and private sectors.
This change in leadership comes amidst Medtronic’s plans to spin off its diabetes unit, a move that aligns with its strategy to focus on specific areas of growth. The company has yet to provide detailed insights into how Quinn’s legal and strategic expertise will guide Medtronic through this process, but her track record suggests she is well-equipped to handle the impending changes.
For more details on Quinn’s move and Medtronic’s plans, you can view the original announcement here.